Hyperthermotherapy added to the multidisciplinary therapy for penile cancer.

Masahiro Kuroda, T. Tsushima, Yasutomo Nasu, Jun-Ichi Asaumi, K. Nishikawa, X. S. Gao, I. Joja, Yoshihiro Takeda, I. Togami, E. Makihata

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

We performed a long-term follow-up of 4 patients with penile cancer who underwent hyperthermotherapy from August 1985 until August 1992. Hyperthermia was applied using a frequency of 350 MHz with a waveguide applicator twice a week for 60 min each for an average of 9.5 times (varying from 6 to 13 times). The total heating time that the temperature of urethra could be kept above 42 degrees C, was 166 min on the average (ranging from 0 to 463 min). Two patients classified as stage I according to the Jackson classification and 1 patient classified as stage IV underwent combined radiotherapy and received an average radiation dose of 53 Gy (range, 40-70 Gy). Among these patients 2 underwent combined chemotherapy with bleomycin or peplomycin. Malignant cells disappeared posttherapeutically and in August 1992, after an average of 5 years and 9 months (varying from 4 years 6 months to 6 years 10 months), the patients were free of recurrences. The one patient on stage IV had extensive invasion of the abdominal wall, but still recovered completely. One patient on stage III underwent combined chemotherapy and hyperthermotherapy, but heating had obviously been insufficient. There was a residue of malignant cells after the treatment and we performed a penectomy. Regarding functional preservation of the penis a multidisciplinary therapy incorporating hyperthermotherapy can be expected to increase the curativity. This indicates that it could induce in an advanced case, where an operation would be difficult, complete remission.

Original languageEnglish
Pages (from-to)169-174
Number of pages6
JournalActa Medica Okayama
Volume47
Issue number3
Publication statusPublished - Jun 1993

Fingerprint

Penile Neoplasms
Chemotherapy
Peplomycin
Heating
Applicators
Bleomycin
Radiotherapy
Dosimetry
Waveguides
Therapeutics
Drug Therapy
Penis
Temperature
Abdominal Wall
Urethra
Fever
Radiation
Recurrence

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Kuroda, M., Tsushima, T., Nasu, Y., Asaumi, J-I., Nishikawa, K., Gao, X. S., ... Makihata, E. (1993). Hyperthermotherapy added to the multidisciplinary therapy for penile cancer. Acta Medica Okayama, 47(3), 169-174.

Hyperthermotherapy added to the multidisciplinary therapy for penile cancer. / Kuroda, Masahiro; Tsushima, T.; Nasu, Yasutomo; Asaumi, Jun-Ichi; Nishikawa, K.; Gao, X. S.; Joja, I.; Takeda, Yoshihiro; Togami, I.; Makihata, E.

In: Acta Medica Okayama, Vol. 47, No. 3, 06.1993, p. 169-174.

Research output: Contribution to journalArticle

Kuroda, M, Tsushima, T, Nasu, Y, Asaumi, J-I, Nishikawa, K, Gao, XS, Joja, I, Takeda, Y, Togami, I & Makihata, E 1993, 'Hyperthermotherapy added to the multidisciplinary therapy for penile cancer.', Acta Medica Okayama, vol. 47, no. 3, pp. 169-174.
Kuroda, Masahiro ; Tsushima, T. ; Nasu, Yasutomo ; Asaumi, Jun-Ichi ; Nishikawa, K. ; Gao, X. S. ; Joja, I. ; Takeda, Yoshihiro ; Togami, I. ; Makihata, E. / Hyperthermotherapy added to the multidisciplinary therapy for penile cancer. In: Acta Medica Okayama. 1993 ; Vol. 47, No. 3. pp. 169-174.
@article{a45404e360ac4aed98c9d05f0c4d8f84,
title = "Hyperthermotherapy added to the multidisciplinary therapy for penile cancer.",
abstract = "We performed a long-term follow-up of 4 patients with penile cancer who underwent hyperthermotherapy from August 1985 until August 1992. Hyperthermia was applied using a frequency of 350 MHz with a waveguide applicator twice a week for 60 min each for an average of 9.5 times (varying from 6 to 13 times). The total heating time that the temperature of urethra could be kept above 42 degrees C, was 166 min on the average (ranging from 0 to 463 min). Two patients classified as stage I according to the Jackson classification and 1 patient classified as stage IV underwent combined radiotherapy and received an average radiation dose of 53 Gy (range, 40-70 Gy). Among these patients 2 underwent combined chemotherapy with bleomycin or peplomycin. Malignant cells disappeared posttherapeutically and in August 1992, after an average of 5 years and 9 months (varying from 4 years 6 months to 6 years 10 months), the patients were free of recurrences. The one patient on stage IV had extensive invasion of the abdominal wall, but still recovered completely. One patient on stage III underwent combined chemotherapy and hyperthermotherapy, but heating had obviously been insufficient. There was a residue of malignant cells after the treatment and we performed a penectomy. Regarding functional preservation of the penis a multidisciplinary therapy incorporating hyperthermotherapy can be expected to increase the curativity. This indicates that it could induce in an advanced case, where an operation would be difficult, complete remission.",
author = "Masahiro Kuroda and T. Tsushima and Yasutomo Nasu and Jun-Ichi Asaumi and K. Nishikawa and Gao, {X. S.} and I. Joja and Yoshihiro Takeda and I. Togami and E. Makihata",
year = "1993",
month = "6",
language = "English",
volume = "47",
pages = "169--174",
journal = "Acta Medica Okayama",
issn = "0386-300X",
publisher = "Okayama University",
number = "3",

}

TY - JOUR

T1 - Hyperthermotherapy added to the multidisciplinary therapy for penile cancer.

AU - Kuroda, Masahiro

AU - Tsushima, T.

AU - Nasu, Yasutomo

AU - Asaumi, Jun-Ichi

AU - Nishikawa, K.

AU - Gao, X. S.

AU - Joja, I.

AU - Takeda, Yoshihiro

AU - Togami, I.

AU - Makihata, E.

PY - 1993/6

Y1 - 1993/6

N2 - We performed a long-term follow-up of 4 patients with penile cancer who underwent hyperthermotherapy from August 1985 until August 1992. Hyperthermia was applied using a frequency of 350 MHz with a waveguide applicator twice a week for 60 min each for an average of 9.5 times (varying from 6 to 13 times). The total heating time that the temperature of urethra could be kept above 42 degrees C, was 166 min on the average (ranging from 0 to 463 min). Two patients classified as stage I according to the Jackson classification and 1 patient classified as stage IV underwent combined radiotherapy and received an average radiation dose of 53 Gy (range, 40-70 Gy). Among these patients 2 underwent combined chemotherapy with bleomycin or peplomycin. Malignant cells disappeared posttherapeutically and in August 1992, after an average of 5 years and 9 months (varying from 4 years 6 months to 6 years 10 months), the patients were free of recurrences. The one patient on stage IV had extensive invasion of the abdominal wall, but still recovered completely. One patient on stage III underwent combined chemotherapy and hyperthermotherapy, but heating had obviously been insufficient. There was a residue of malignant cells after the treatment and we performed a penectomy. Regarding functional preservation of the penis a multidisciplinary therapy incorporating hyperthermotherapy can be expected to increase the curativity. This indicates that it could induce in an advanced case, where an operation would be difficult, complete remission.

AB - We performed a long-term follow-up of 4 patients with penile cancer who underwent hyperthermotherapy from August 1985 until August 1992. Hyperthermia was applied using a frequency of 350 MHz with a waveguide applicator twice a week for 60 min each for an average of 9.5 times (varying from 6 to 13 times). The total heating time that the temperature of urethra could be kept above 42 degrees C, was 166 min on the average (ranging from 0 to 463 min). Two patients classified as stage I according to the Jackson classification and 1 patient classified as stage IV underwent combined radiotherapy and received an average radiation dose of 53 Gy (range, 40-70 Gy). Among these patients 2 underwent combined chemotherapy with bleomycin or peplomycin. Malignant cells disappeared posttherapeutically and in August 1992, after an average of 5 years and 9 months (varying from 4 years 6 months to 6 years 10 months), the patients were free of recurrences. The one patient on stage IV had extensive invasion of the abdominal wall, but still recovered completely. One patient on stage III underwent combined chemotherapy and hyperthermotherapy, but heating had obviously been insufficient. There was a residue of malignant cells after the treatment and we performed a penectomy. Regarding functional preservation of the penis a multidisciplinary therapy incorporating hyperthermotherapy can be expected to increase the curativity. This indicates that it could induce in an advanced case, where an operation would be difficult, complete remission.

UR - http://www.scopus.com/inward/record.url?scp=0027616466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027616466&partnerID=8YFLogxK

M3 - Article

C2 - 8379345

AN - SCOPUS:0027616466

VL - 47

SP - 169

EP - 174

JO - Acta Medica Okayama

JF - Acta Medica Okayama

SN - 0386-300X

IS - 3

ER -